Lead identification and optimization of diaminopyrimidines as histamine H4 receptor ligands
- PMID: 20012148
- DOI: 10.1007/s00011-009-0143-2
Lead identification and optimization of diaminopyrimidines as histamine H4 receptor ligands
Abstract
Background: The human histamine H(4) receptor (hH(4)R) is a promising new target in the therapy of inflammatory or immune system diseases.
Methods: For the development of new hH(4)R ligands, a broad virtual screening was performed and two hits were identified. Their annelated heterocyclic core was optimized with regard to affinity and potency.
Results: Pharmacological characterization of the resulting diaminopyrimidines revealed different agonist and antagonist properties within the same scaffold.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
